HER2/Neu Positive Completed Phase Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00555152Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In SituTreatment